Botanical species · safety record

Scutellaria lateriflora

The EFSA Compendium of Botanicals holds 3 constituent measurements and 2 adverse-effect records for Scutellaria lateriflora. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Scutellaria lateriflora L.

3Constituent measurements

2Safety records

4Cited sources

428Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 428 licensed products naming Scutellaria lateriflora as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

Dry
Extract Type TBA
Fresh

Source material stated

Aerial (powder)
Aerial parts
Dried aerial part(s)
Flower
Flower extract
Flowering top(s)
Fresh above ground parts
Herb

What the records describe

Constituents measured

Plant parts

Preparations

Effect types

Target tissues

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Clerodane-type diterpenes	Aerial part of plants	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Coumarins	Aerial part of plants	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Lignans	Aerial part of plants	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	No resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

Effect	Target tissue	Plant part	Preparation	Test organism	Test type	Source
Reproductive	Urogenital	Roots and other underground parts	—	Rat (as animal)	Reproduction toxicity	Resolve DOI
Digestive	Digestive	Aerial part of plants	Solvent extraction	Rat (as animal)	In vitro	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Jurgens, TM. Potential Toxicities of herbal therapies in the developing fetus. Birth defects research part b-developmental and reproductive toxicology, 2003, vol. 68, no. 6, p. 496-498. DOI
Kuroda, Minpei., Iwabuchi, Katsura., Mimaki, Yoshihiro. Chemical Constituents of the Aerial Parts of Scutellaria lateriflora and their alpha-Glucosidase Inhibitory Activities . Natural product communications, 2012, vol. 7, no. 4, p. 471-474.
Li, Jing., Ding, Yuanqing., Li, Xing-Cong., Ferreira, Daneel., Khan, Shabana., Smillie, Troy., Khan, Ikhlas A. Scuteflorins A and B, Dihydropyranocoumarins from Scutellaria lateriflora . Journal of natural products, 2009, vol. 72, no. 6, p. 983-987. DOI
Bruno, M., Cruciata, M., Bondi, ML., Piozzi, F., de la Torre, MC., Rodriguez, B., Servettaz, O. Neo-clerodane diterpenoids from Scutellaria lateriflora. PHYTOCHEMISTRY, 1998, vol. 48, no. 4, p. 687-691. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature